Report overview
Biomarkers are a class of markers related to cell growth and proliferation that have been proposed in recent years with the development of immunology and molecular biology techniques. Biomarkers can not only discuss the pathogenesis at the molecular level, but also have a unique advantage in accurately and sensitively evaluating early and low-level damage. They can provide early warning, which largely provides clinicians with auxiliary diagnosis Basis.
This report aims to provide a comprehensive presentation of the global market for Clinical Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Biomarkers. This report contains market size and forecasts of Clinical Biomarkers in global, including the following market information:
Global Clinical Biomarkers Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Clinical Biomarkers market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Diagnostic Biomarkers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Clinical Biomarkers include Abbott Laboratories, Agilent Technologies, Inc., ALCEDIAG, Becton, Dickinson and Company, bioM?rieux S.A., Bio-Rad Laboratories, Inc., CENTOGENE N.V., F. Hoffmann-La Roche Ltd. and Enzo Biochem Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Clinical Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Biomarkers Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Clinical Biomarkers Market Segment Percentages, by Type, 2022 (%)
Diagnostic Biomarkers
Predictive Biomarkers
Prognostic Biomarkers
Global Clinical Biomarkers Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Clinical Biomarkers Market Segment Percentages, by Application, 2022 (%)
Research and Academic Laboratories
Biopharmaceutical and Biotech Companies
Diagnostic Centers
Others
Global Clinical Biomarkers Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Clinical Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Biomarkers revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Clinical Biomarkers revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agilent Technologies, Inc.
ALCEDIAG
Becton, Dickinson and Company
bioM?rieux S.A.
Bio-Rad Laboratories, Inc.
CENTOGENE N.V.
F. Hoffmann-La Roche Ltd.
Enzo Biochem Inc.
Illumina, Inc.
Myriad Genetics, Inc.
Quest Diagnostics Incorporated
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Biomarkers, market overview.
Chapter 2: Global Clinical Biomarkers market size in revenue.
Chapter 3: Detailed analysis of Clinical Biomarkers company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
